Al-Hertani, W.; Pathak, R.R.; Evuarherhe, O.; Carter, G.; Schaeffer-Koziol, C.R.; Whiteman, D.A.H.; Wright, E.
Intravenous Idursulfase for the Treatment of Mucopolysaccharidosis Type II: A Systematic Literature Review. Int. J. Mol. Sci. 2024, 25, 8573.
https://doi.org/10.3390/ijms25168573
AMA Style
Al-Hertani W, Pathak RR, Evuarherhe O, Carter G, Schaeffer-Koziol CR, Whiteman DAH, Wright E.
Intravenous Idursulfase for the Treatment of Mucopolysaccharidosis Type II: A Systematic Literature Review. International Journal of Molecular Sciences. 2024; 25(16):8573.
https://doi.org/10.3390/ijms25168573
Chicago/Turabian Style
Al-Hertani, Walla, Ravi R. Pathak, Obaro Evuarherhe, Gemma Carter, Carolyn R. Schaeffer-Koziol, David A. H. Whiteman, and Ekaterina Wright.
2024. "Intravenous Idursulfase for the Treatment of Mucopolysaccharidosis Type II: A Systematic Literature Review" International Journal of Molecular Sciences 25, no. 16: 8573.
https://doi.org/10.3390/ijms25168573
APA Style
Al-Hertani, W., Pathak, R. R., Evuarherhe, O., Carter, G., Schaeffer-Koziol, C. R., Whiteman, D. A. H., & Wright, E.
(2024). Intravenous Idursulfase for the Treatment of Mucopolysaccharidosis Type II: A Systematic Literature Review. International Journal of Molecular Sciences, 25(16), 8573.
https://doi.org/10.3390/ijms25168573